Immucor Inc - Company Profile
Powered by
All the data and insights you need on Immucor Inc in one report.
- Save hours of research time and resources with
our up-to-date Immucor Inc Strategy Report
- Understand Immucor Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Immucor Inc (Immucor) provides transfusion and transplantation diagnostic products. The company develops, manufactures and markets serology-based reagents and instruments for pre-transfusion typing and screening of blood; and assays for pre-transplant typing and screening and post-transplant monitoring. It also offers coagulation products to help determine a patient’s risk of excessive bleeding and antibody count in thrombosis. The company develops molecular and antibody-based assays using its ELISA and xMAP technology. It serves hospitals, donor centers and reference laboratories worldwide. The company markets products directly and through a network of distributors in the US, Belgium, India, Italy, Japan, Portugal, Canada, France, Germany, Spain and the UK and rest of the world. Immucor is headquartered in Norcross, Georgia, the US.
Immucor Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Transfusion | Coagulation Labs | Galileo Echo |
Instruments | HLA registry labs | Capture |
Reagents | Immucor | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Immucor Inc | Thermo Fisher Scientific Inc | Abbott Laboratories | Bio-Rad Laboratories Inc | Ortho Clinical Diagnostics Holdings Plc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Norcross | Waltham | Abbott Park | Hercules | Raritan |
State/Province | Georgia | Massachusetts | Illinois | California | New Jersey |
No. of Employees | - | 130,000 | 115,000 | 8,200 | 4,800 |
Entity Type | Private | Public | Public | Public | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Avi Pelossof | President; Chief Executive Officer | Senior Management | 2018 | - |
Dominique Petitgenet | Chief Operating Officer; Chief Financial Officer | Senior Management | 2017 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer